Properties
Description
Delgocitinib is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and TYK2.
Molecular Formula
C16H18N6O
Targets
JAK1: 2.8 nM; JAK2: 2.6 nM; JAK3: 13 nM; TYK2: 58 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
Delgocitinib can be employed to study JAK inhibition and its effects in dermatological and inflammatory conditions.